MedTrace Logo

Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices Viscol

NCT06142643 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2025-08-27

Study results available
· View outcomes & findings →

Summary

Evaluation of safety and performance of HA based injectable device for skin quality improvement

Conditions

  • Aesthetic Dermatology

Interventions

DEVICE

Dermal Filler Device

Injection of the device by investigators according to the IFU

Sponsors & Collaborators

  • Eurofins Dermscan Pharmascan

    collaborator INDUSTRY

  • Kylane Laboratoires

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-08
Primary Completion
2024-08-20
Completion
2024-08-20

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06142643 on ClinicalTrials.gov